Figure 3.
Figure 3. Contribution of p110γ and p110δ activity in thymocyte development in vitro. (A) Representative flow cytometry profiles of fetal thymic organ cultures harvested from day 14.5 WT, p110δ-/-, and p110γ-/- embryos that were treated with either vehicle control or p110δ-specific inhibitor IC87114 (10 μM) for 1 week. (B) Percentage reduction in DP thymocyte population after treatment with IC87114 compared with control treatment (mean ± SE; n = 3).

Contribution of p110γ and p110δ activity in thymocyte development in vitro. (A) Representative flow cytometry profiles of fetal thymic organ cultures harvested from day 14.5 WT, p110δ-/-, and p110γ-/- embryos that were treated with either vehicle control or p110δ-specific inhibitor IC87114 (10 μM) for 1 week. (B) Percentage reduction in DP thymocyte population after treatment with IC87114 compared with control treatment (mean ± SE; n = 3).

Close Modal

or Create an Account

Close Modal
Close Modal